Below is a rank of the top 15 pharmacies that generated the most revenue from dispensing specialty pharmaceuticals in 2018, according to the Drug Channels Institute.
1. CVS Specialty/ Aetna Specialty Pharmacy — $37 billion
2. Accredo/ Freedom Fertility/ Cigna Specialty Pharmacy — $30.7 billion
3. Alliance Rx Walgreens Prime / Walgreens stores — $19.6 billion
4. BriovaRx (owned by UnitedHealth Group’s OptumRx) — $16.8 billion
5. Diplomat Pharmacy — $4.8 billion
6. Humana Specialty Pharmacy — $3.2 billion
7. Kroger Specialty Pharmacy / Kroger stores — $2.8 billion
8. Specialty Pharmacy Solutions (owned by McKesson) — $1.6 billion
9. U.S. Bioservices (owned by AmerisourceBergen) — $1.4 billion
10. Walmart Specialty Pharmacy — $1 billion
11. SenderraRx — $800 million
12. PANTHERx —$700 million
13. BioPlus Specialty Pharmacy Services — $700 million
14. Onco360/ CareMed — $600 million
15. Amber Pharmacy/ Hy-Vee Pharmacy Solutions — $500 million
More articles on pharmacy:
Judge blocks HHS rule requiring drug prices in TV ads
Nation’s 1st prescription drug affordability board goes into effect
11 healthcare pharma leaders offer advice on controlling drug spend
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.